UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.17 -2.76 (-3.37%) GOLD FUTURES
2,314.70 +11.80 (+0.51%) DOW
37,930.63 +114.71 (+0.30%) Bitcoin GBP
45,590.47 -2,851.16 (-5.89%)
Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:53PM EDT. Market open.
| Previous close | 6.05 |
| Open | 6.01 |
| Bid | 6.05 x 200 |
| Ask | 6.07 x 100 |
| Day's range | 6.01 - 6.19 |
| 52-week range | 1.74 - 6.46 |
| Volume | |
| Avg. volume | 1,574,906 |
| Market cap | 1.87B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Amneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past week
When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...
- GuruFocus.com
Amneal Pharmaceuticals Inc (AMRX) Reports Mixed 2023 Financial Results
Despite Revenue Growth, Company Faces GAAP Net Loss and Provides 2024 Guidance
- Simply Wall St.
Insiders the biggest winners as Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) market cap rises to US$1.8b
Key Insights Amneal Pharmaceuticals' significant insider ownership suggests inherent interests in company's expansion...
© 2024 Yahoo. All rights reserved.